Nice to see the shares carve out a 52w high and have some momentum.

Hope it continues, and takes us above $30. the KC PPE acquisition and subsequent cap raise seems to have got the tick of approval from the market so far.

Ansell has just updated its FY23 guidance and issued FY24 guidance.Good news and bad news.

ASX Announcement

Good news: FY23 EPS to be in the range US$1.17-1.18, within previously guided $1.10-1.20 - in fact towards the upper end.

Bad news:

Guidance for statutory EPS for FY24 is US$0.57-0.77, compared with the current consensus of US$1.22.

The downgrade is due to several exceptional items, including investments in cost reduction planned for the the year. The Adjust EPS guidance without the exceptional items is US$0.92-1.12, still well below the current consensus.

Clearly, $ANN - which is generally consider a well-run industrial with category leading products, is struggling having been hit by post-pandemic softness in its healthcare division, supply chain issues, write-offs in Russia, cost inflation and not - potentially, a slowdown.

The picture of evolving EPS consensus - not yet updated for today - does not make pleasant viewing.

It will be interesting to see the SP response.

Disc: Not held, but previously held in RL.

Hey guys, a while ago, Claude Walker let me publish a write-up about Ansell on his website. I thought I might as well share it here as there looks to be little coverage and context on this stock in strawman.

https://arichlife.com.au/should-ansell-asx-ann-shares-be-trading-at-at-just-12-6-times-earnings/

Front page news on the ABC - allegations of modern slavery for Ansell's third paty suppier, Brightway.

Case lodged in a US court alleging that Ansell and Kimberly-Clark, "knowingly profited" off exploitation by contracting the factory to make latex gloves.

https://www.abc.net.au/news/2022-08-24/ansell-slave-labour-brightway/101362990